Role of Endogenous Lipopolysaccharides in Neurological Disorders

• Published in: Cells (Basel, Switzerland) Vol. 11; no. 24; p. 4038
• Main Authors: Kalyan, Manjunath, Tousif, Ahmed Hediyal, Sonali, Sharma, Vichitra, Chandrasekaran, Sunanda, Tuladhar, Praveenraj, Sankar Simla, Ray, Bipul, Gorantla, Vasavi Rakesh, Rungratanawanich, Wiramon, Mahalakshmi, Arehally M, Qoronfleh, M Walid, Monaghan, Tanya M, Song, Byoung-Joon, Essa, Musthafa Mohamed, Chidambaram, Saravana Babu
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-12-2022; MDPI
• Subjects: Alzheimer's disease; Antigens; Apoptosis; Astrocytes; Bacteria; Biochemistry; Blood-brain barrier; Cell death; Cytokines; Dementia disorders; Dendritic cells; Development and progression; Dysbacteriosis; Dysbiosis; E coli; Endotoxemia; Enzymes; Gram-negative bacteria; Gram-positive bacteria; gut microbiota; gut–brain axis; Health aspects; Homeostasis; Humans; Immunological memory; Immunostimulation; Inflammation; Intestinal microflora; Intestine; Leukocytes (neutrophilic); Lipids; lipopolysaccharide; Lipopolysaccharides; Lipopolysaccharides - adverse effects; Metabolic disorders; Metabolites; Microbiota; Microglia; Microorganisms; Mitochondria; Nervous system diseases; neurodegeneration; Neurodegenerative Diseases; neuroinflammation; Neuroinflammatory Diseases; Neurological disorders; Paralysis; Permeability; Proteins; Review; Senescence; India; neurodegeneration; gut–brain axis; lipopolysaccharide; neuroinflammation; gut microbiota; endotoxemia
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11244038

Lipopolysaccharide (LPS) is a cell-wall immunostimulatory endotoxin component of Gram-negative bacteria. A growing body of evidence reveals that alterations in the bacterial composition of the intestinal microbiota (gut dysbiosis) disrupt host immune homeostasis and the intestinal barrier function. Microbial dysbiosis leads to a proinflammatory milieu and systemic endotoxemia, which contribute to the development of neurodegenerative diseases and metabolic disorders. Two important pathophysiological hallmarks of neurodegenerative diseases (NDDs) are oxidative/nitrative stress and inflammation, which can be initiated by elevated intestinal permeability, with increased abundance of pathobionts. These changes lead to excessive release of LPS and other bacterial products into blood, which in turn induce chronic systemic inflammation, which damages the blood-brain barrier (BBB). An impaired BBB allows the translocation of potentially harmful bacterial products, including LPS, and activated neutrophils/leucocytes into the brain, which results in neuroinflammation and apoptosis. Chronic neuroinflammation causes neuronal damage and synaptic loss, leading to memory impairment. LPS-induced inflammation causes inappropriate activation of microglia, astrocytes, and dendritic cells. Consequently, these alterations negatively affect mitochondrial function and lead to increases in oxidative/nitrative stress and neuronal senescence. These cellular changes in the brain give rise to specific clinical symptoms, such as impairment of locomotor function, muscle weakness, paralysis, learning deficits, and dementia. This review summarizes the contributing role of LPS in the development of neuroinflammation and neuronal cell death in various neurodegenerative diseases.